Mitochondrial Encephalopathy Lactic Acidosis With Stroke-Like Episodes (MELAS) – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
A rare neurometabolic genetic disorder that is progressive and multisystemic due to mitochondrial dysfunction and that is characterized by encephalomyopathy, lactic acidosis, and stroke-like episodes. Etiology- MELAS can result from mutations in one of several genes, including MT-ND1, MT-ND5, MT-TH, MT-TL1, and MT-TV. These genes are found in the DNA of cellular structures called mitochondria, which convert the energy from food into a form that cells can use. Epidemiology- Estimated prevalence has been reported about 0.2/100,000 in Japan. It is one of the most frequent mitochondrial disorders, which are estimated to affect 1/10,000 people. The competitive landscape of Mitochondrial Encephalopathy Lactic Acidosis With Stroke-Like Episodes (MELAS) includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Mitochondrial Encephalopathy Lact...